Literature DB >> 2297205

Artefacts in measurement of blood pressure and lack of target organ involvement in the assessment of patients with treatment-resistant hypertension.

A D Mejia1, B M Egan, N J Schork, A J Zweifler.   

Abstract

OBJECTIVE: To determine the relative importance of factors known to cause therapy-resistant hypertension, and to derive an efficient approach to the evaluation of this problem in clinical practice.
DESIGN: Consecutive sample.
SETTING: University hospital hypertension clinic and clinical research center. PATIENTS: Fifteen patients referred for management of refractory hypertension and found to have a seated diastolic blood pressure greater than 95 mm Hg while taking a standard dose of hydrochlorothiazide, propranolol, and hydralazine or its equivalent for at least 4 weeks.
MEASUREMENTS AND MAIN RESULTS: Seven patients (group 1) had normal, resting mean intra-arterial blood pressure (mean pressure less than 107 mm Hg) and eight had elevated pressure (group 2). Patients in group 1 had minimal or not target organ involvement whereas those in group 2 had higher minimum vascular resistance by forearm plethysmography and greater interventricular septal wall thickness. Factors contributing to resistant hypertension, particularly in group 1, were "office hypertension" (clinic systolic blood pressure at least 20 mm Hg higher than home systolic blood pressure), pseudohypertension (cuff diastolic blood pressure at least 15 mm Hg higher than simultaneously determined intra-arterial pressure), and "cuff-inflation hypertension" (intra-arterial diastolic blood pressure rise of at least 15 mm Hg during cuff inflation).
CONCLUSION: Home blood pressure monitoring and echocardiography are recommended as initial steps in the evaluation of patients with resistant hypertension. Intra-arterial blood pressure measurement is particularly helpful in patients with resistant hypertension who do not have office hypertension yet have normal septal thickness on echocardiography.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2297205     DOI: 10.7326/0003-4819-112-4-270

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  16 in total

Review 1.  Resistant hypertension and the Birmingham Hypertension Square.

Authors:  D C Felmeden; G Y Lip
Journal:  Curr Hypertens Rep       Date:  2001-06       Impact factor: 5.369

2.  Ambulatory blood pressure measurement in general practice.

Authors:  J P Cox; K O'Malley; E O'Brien
Journal:  Br J Gen Pract       Date:  1992-10       Impact factor: 5.386

Review 3.  What do you do when the blood pressure is up? An approach to the known hypertensive who has an elevated blood pressure.

Authors:  R L Schiff; M H Cohen; A Balson
Journal:  J Gen Intern Med       Date:  1991 Jan-Feb       Impact factor: 5.128

4.  Target organ complications and prognostic significance of alerting reaction: analysis from the Dallas Heart Study.

Authors:  Alejandro Velasco; Colby Ayers; Sandeep R Das; James A de Lemos; Amit Khera; Ronald G Victor; Norman M Kaplan; Wanpen Vongpatanasin
Journal:  J Hypertens       Date:  2016-02       Impact factor: 4.844

Review 5.  Review of resistant hypertension.

Authors:  C Venkata S Ram
Journal:  Curr Hypertens Rep       Date:  2006-10       Impact factor: 5.369

6.  Target blood pressure for antihypertensive therapy in patients with proteinuric renal disease.

Authors:  L A Hebert
Journal:  Curr Hypertens Rep       Date:  1999-10       Impact factor: 5.369

Review 7.  Report of the Canadian Hypertension Society Consensus Conference: 2. Diagnosis of hypertension in adults.

Authors:  R B Haynes; Y Lacourcière; S W Rabkin; F H Leenen; A G Logan; N Wright; C E Evans
Journal:  CMAJ       Date:  1993-08-15       Impact factor: 8.262

8.  Prevalence and determinants of resistant hypertension in a sample of patients followed in Italian hypertension centers: results from the MINISAL-SIIA study program.

Authors:  F Galletti; A Barbato
Journal:  J Hum Hypertens       Date:  2016-03-03       Impact factor: 3.012

Review 9.  Treatment resistant hypertension--investigation and conservative management.

Authors:  Franz Weber; Manfred Anlauf
Journal:  Dtsch Arztebl Int       Date:  2014-06-20       Impact factor: 5.594

10.  Prevalence of optimal treatment regimens in patients with apparent treatment-resistant hypertension based on office blood pressure in a community-based practice network.

Authors:  Brent M Egan; Yumin Zhao; Jiexiang Li; W Adam Brzezinski; Thomas M Todoran; Robert D Brook; David A Calhoun
Journal:  Hypertension       Date:  2013-08-05       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.